Literature DB >> 10655275

Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen.

H Marusawa1, S Uemoto, M Hijikata, Y Ueda, K Tanaka, K Shimotohno, T Chiba.   

Abstract

Several recent reports have shown that hepatitis B virus (HBV) could be frequently transmitted to the recipients from donors who have antibodies to hepatitis B core antigen (anti-HBc) through liver transplantation. We provide here the molecular evidence of latent HBV infection accompanied with ongoing viral replication in the liver tissue of anti-HBc-positive healthy individuals. HBV DNA was detectable in 13 of 14 healthy donors who were positive for both anti-HBc and antibodies to hepatitis B surface antigen (anti-HBs), but in none of 3 who were positive for anti-HBs alone. The detected HBV genomes from these subjects included covalently closed circular DNA and pregenomic RNA, the replication intermediate of HBV. Notably, 5 of 7 cases tested were predominantly infected with wild type HBV strains without any mutations in the precore and core promoter regions under the presence of circulating antibody to hepatitis B e antigen. Interestingly, a predominant clone detected in one donor showed a 63-nucleotide deletion in the precore region including an encapsidation signal sequence. Our findings indicate that the majority of healthy individuals positive for anti-HBc, which had been assumed to denote a past history of transient HBV infection, were latently infected with the episomal form of HBV accompanied by ongoing viral replication and few nucleotide mutations in the precore and core regions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10655275     DOI: 10.1002/hep.510310232

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  49 in total

1.  HBXIP functions as a cofactor of survivin in apoptosis suppression.

Authors:  Hiroyuki Marusawa; Shu-Ichi Matsuzawa; Kate Welsh; Hua Zou; Robert Armstrong; Ingo Tamm; John C Reed
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

Review 2.  Hepatitis B virus infection in liver transplant candidates and recipients.

Authors:  Patrick Yachimski; Raymond T Chung
Journal:  MedGenMed       Date:  2005-04-18

3.  Novel mechanism of antibodies to hepatitis B virus in blocking viral particle release from cells.

Authors:  Avidan U Neumann; Sandra Phillips; Idit Levine; Samreen Ijaz; Harel Dahari; Rachel Eren; Shlomo Dagan; Nikolai V Naoumov
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

4.  The association of hepatitis B virus infection with B-cell non-Hodgkin lymphoma - a review.

Authors:  Fabrizio Marcucci; Enea Spada; Alfonso Mele; Carmelo Antonio Caserta; Alessandro Pulsoni
Journal:  Am J Blood Res       Date:  2012-01-01

5.  Hepatitis B virus e antigen loss during adefovir dipivoxil therapy is associated with enhanced virus-specific CD4+ T-cell reactivity.

Authors:  Helen Cooksley; Shilpa Chokshi; Yafit Maayan; Heiner Wedemeyer; Pietro Andreone; Richard Gilson; Thomas Warnes; Simona Paganin; Fabien Zoulim; David Frederick; Avidan U Neumann; Carol L Brosgart; Nikolai V Naoumov
Journal:  Antimicrob Agents Chemother       Date:  2007-11-05       Impact factor: 5.191

6.  Management of hepatitis B virus reactivation in patients with hematological malignancies treated with chemotherapy.

Authors:  D Francisci; F Falcinelli; E Schiaroli; M Capponi; B Belfiori; L Flenghi; F Baldelli
Journal:  Infection       Date:  2009-11-10       Impact factor: 3.553

7.  Significance of anti-HBc only in blood donors: a serological and virological study after hepatitis B vaccination.

Authors:  Gianluca Gessoni; Samanta Beggio; Paolo Barin; Mosè Favarato; Claudio Galli; Sara Valverde; Massimo Boscolo Nata; Maria Monica Salvadego; Giorgio Marchiori
Journal:  Blood Transfus       Date:  2013-02-21       Impact factor: 3.443

8.  Novel and highly sensitive immunoassay for total hepatitis B surface antigen, including that complexed with hepatitis B surface antibody.

Authors:  Akihiro Matsumoto; Masayasu Imaizumi; Yasuhito Tanaka; Shuhei Nishiguchi; Hiroshi Yatsuhashi; Takehiko Ishida; Kazushige Moriyama; Katsumi Aoyagi; Eiji Tanaka
Journal:  J Gastroenterol       Date:  2016-07-26       Impact factor: 7.527

9.  Antibody to hepatitis B core antigen as a screening test for occult hepatitis B virus infection in Egyptian chronic hepatitis C patients.

Authors:  Assem El-Sherif; Mohamed Abou-Shady; Hany Abou-Zeid; Ahmed Elwassief; Ashraf Elbahrawy; Yoshihide Ueda; Tsutomu Chiba; Abdel-Moneim Hosney
Journal:  J Gastroenterol       Date:  2009-03-07       Impact factor: 7.527

10.  Significance of prior hepatitis B virus infection in the development of hepatocellular carcinoma in patients with chronic hepatitis C.

Authors:  Fumio Imazeki; Osamu Yokosuka; Kenichi Fukai; Akira Hiraide; Hiromitsu Saisho
Journal:  Dig Dis Sci       Date:  2003-09       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.